PL357508A1 - Sposób oczyszczania hCG oraz rekombinowana hCG oczyszczona tym sposobem - Google Patents

Sposób oczyszczania hCG oraz rekombinowana hCG oczyszczona tym sposobem

Info

Publication number
PL357508A1
PL357508A1 PL01357508A PL35750801A PL357508A1 PL 357508 A1 PL357508 A1 PL 357508A1 PL 01357508 A PL01357508 A PL 01357508A PL 35750801 A PL35750801 A PL 35750801A PL 357508 A1 PL357508 A1 PL 357508A1
Authority
PL
Poland
Prior art keywords
hcg
purification
recombinant
ion
purified
Prior art date
Application number
PL01357508A
Other languages
English (en)
Other versions
PL205149B1 (pl
Inventor
Gianfranco Paradisi
Mara Rossi
Laura Scaglia
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of PL357508A1 publication Critical patent/PL357508A1/pl
Publication of PL205149B1 publication Critical patent/PL205149B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
PL357508A 2000-02-22 2001-01-22 Sposób przygotowania rekombinowanej hCG PL205149B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00103690 2000-02-22

Publications (2)

Publication Number Publication Date
PL357508A1 true PL357508A1 (pl) 2004-07-26
PL205149B1 PL205149B1 (pl) 2010-03-31

Family

ID=8167925

Family Applications (1)

Application Number Title Priority Date Filing Date
PL357508A PL205149B1 (pl) 2000-02-22 2001-01-22 Sposób przygotowania rekombinowanej hCG

Country Status (31)

Country Link
US (2) US7297777B2 (pl)
EP (2) EP1752466A3 (pl)
JP (1) JP4588960B2 (pl)
KR (1) KR100806911B1 (pl)
CN (1) CN100482679C (pl)
AT (1) ATE406378T1 (pl)
AU (2) AU783320B2 (pl)
BG (1) BG65807B1 (pl)
BR (1) BRPI0108556B8 (pl)
CA (1) CA2399020A1 (pl)
CY (1) CY1108460T1 (pl)
CZ (1) CZ303144B6 (pl)
DE (1) DE60135541D1 (pl)
DK (1) DK1257564T3 (pl)
EA (1) EA006605B1 (pl)
EE (1) EE05644B1 (pl)
ES (1) ES2307585T3 (pl)
HR (1) HRP20020650B1 (pl)
HU (2) HU1300063D0 (pl)
IL (2) IL151308A0 (pl)
ME (1) ME00296B (pl)
MX (1) MXPA02007871A (pl)
NO (1) NO328694B1 (pl)
PL (1) PL205149B1 (pl)
PT (1) PT1257564E (pl)
RS (1) RS50741B (pl)
SI (1) SI1257564T1 (pl)
SK (1) SK287146B6 (pl)
UA (2) UA86938C2 (pl)
WO (1) WO2001062773A1 (pl)
ZA (1) ZA200206109B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL151308A0 (en) * 2000-02-22 2003-04-10 Applied Research Systems PURIFICATION OF hCG AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
JP2007513192A (ja) * 2004-10-04 2007-05-24 ノベタイド，リミティド ペプチド用の対イオン交換法
CN1958603B (zh) * 2005-11-04 2010-05-05 上海天伟生物制药有限公司 一种人绒毛膜促性腺素的纯化方法
EA200802426A1 (ru) * 2006-07-11 2009-04-28 Коваль, Антон Александрович Применение хорионического или лютеинизирующего гормона для профилактики или лечения возрастного гипогонадизма
CN101397339B (zh) * 2008-09-24 2012-07-25 上海天伟生物制药有限公司 糖蛋白中去除/灭活病毒的方法
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
CN101792481B (zh) * 2010-03-12 2012-05-30 丽珠医药集团股份有限公司 一种绒毛膜促性腺激素的纯化方法
WO2012120535A2 (en) * 2011-02-03 2012-09-13 Sanzyme Limited A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same
US9757469B2 (en) 2011-03-31 2017-09-12 Ferring B.V. Pharmaceutical preparation
WO2013102921A2 (en) * 2011-11-17 2013-07-11 Sanzyme Limited Hcg - newer treatment modality for type 2 diabetes mellitus (t2dm)
CN103288950A (zh) * 2012-12-28 2013-09-11 青岛九龙生物医药有限公司 改进柱分离工序洗涤液和洗脱液配比去除杂质的方法
CN104101656A (zh) * 2013-04-01 2014-10-15 上海天伟生物制药有限公司 一种促性腺激素的纯度测定方法
US20150065426A1 (en) * 2013-08-27 2015-03-05 Professional Compounding Centers Of America Testosterone Booster Transdermal Compositions
CN105968185A (zh) * 2016-07-20 2016-09-28 宁波人健药业集团股份有限公司 一种绒促性素纯化方法
CN111233999B (zh) * 2020-03-21 2024-02-23 上海浦东明炎生物技术有限公司 一种从人尿中提取人绒毛膜促性腺激素的方法
CN113398251B (zh) * 2021-07-30 2022-08-05 宁波人健药业集团股份有限公司 一种重组人绒毛膜促性腺激素冻干粉针剂及其制备方法
CN116063452A (zh) * 2023-01-03 2023-05-05 杭州浦泰生物科技有限公司 一种人绒毛膜促性腺激素高效纯化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2098261T3 (es) * 1989-02-21 1997-05-01 Univ Washington Formas modificadas de hormonas reproductoras.
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
IT1254370B (it) * 1992-05-22 1995-09-14 Sorin Biomedica Spa Procedimento per la purificazione di proteine da sistemi cellulari.
WO1996029095A1 (en) 1995-03-21 1996-09-26 Applied Research Systems Ars Holding N.V. Hcg liquid formulations
CN1082368C (zh) * 1995-03-21 2002-04-10 应用研究系统Ars股份公司 人绒毛膜促性腺激素液体制剂
ATE295887T1 (de) * 1996-02-20 2005-06-15 Applied Research Systems Heterodimerebildende hybrid-proteine
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
WO1998056806A1 (en) 1997-06-12 1998-12-17 The Regents Of The University Of California A TRANSCRIPTION FACTOR COACTIVATOR PROTEIN, p/CIP
CA2289665C (en) * 1997-06-13 2005-08-09 Genentech, Inc. Protein recovery by chromatography followed by filtration upon a charged layer
US6583109B1 (en) * 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
IL151308A0 (en) * 2000-02-22 2003-04-10 Applied Research Systems PURIFICATION OF hCG AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

Also Published As

Publication number Publication date
HU1300063D0 (hu) 2003-03-28
EE05644B1 (et) 2013-04-15
MEP38908A (en) 2011-02-10
NO20023985D0 (no) 2002-08-21
US20070299001A1 (en) 2007-12-27
NO20023985L (no) 2002-08-21
DK1257564T3 (da) 2008-10-06
EE200200469A (et) 2004-04-15
SK287146B6 (sk) 2010-01-07
EP1752466A2 (en) 2007-02-14
PT1257564E (pt) 2008-09-10
CZ303144B6 (cs) 2012-05-02
EP1257564B1 (en) 2008-08-27
HK1052016A1 (zh) 2003-08-29
PL205149B1 (pl) 2010-03-31
HUP0204231A3 (en) 2005-09-28
ME00296B (me) 2011-05-10
EP1752466A3 (en) 2012-10-10
SK12062002A3 (sk) 2002-12-03
US20030104553A1 (en) 2003-06-05
CN100482679C (zh) 2009-04-29
HUP0204231A2 (hu) 2003-03-28
WO2001062773A1 (en) 2001-08-30
UA78488C2 (en) 2007-04-10
RS50741B (sr) 2010-08-31
EA200200892A1 (ru) 2003-02-27
IL151308A (en) 2009-11-18
AU2680401A (en) 2001-09-03
BG65807B1 (bg) 2009-12-31
HRP20020650A2 (en) 2004-12-31
MXPA02007871A (es) 2003-02-10
SI1257564T1 (sl) 2008-12-31
CY1108460T1 (el) 2014-04-09
ZA200206109B (en) 2003-07-31
JP2003524015A (ja) 2003-08-12
BRPI0108556B8 (pt) 2021-05-25
UA86938C2 (uk) 2009-06-10
CZ20022855A3 (cs) 2002-11-13
CA2399020A1 (en) 2001-08-30
YU60202A (sh) 2005-09-19
BG107000A (en) 2003-04-30
HRP20020650B1 (en) 2011-02-28
US7297777B2 (en) 2007-11-20
AU2006200059A1 (en) 2006-02-02
HU228935B1 (en) 2013-06-28
CN1404485A (zh) 2003-03-19
NO328694B1 (no) 2010-04-26
KR20030001359A (ko) 2003-01-06
EP1257564A1 (en) 2002-11-20
BR0108556A (pt) 2003-01-28
BRPI0108556B1 (pt) 2015-04-14
EA006605B1 (ru) 2006-02-24
ATE406378T1 (de) 2008-09-15
AU783320B2 (en) 2005-10-13
ES2307585T3 (es) 2008-12-01
IL151308A0 (en) 2003-04-10
DE60135541D1 (de) 2008-10-09
JP4588960B2 (ja) 2010-12-01
KR100806911B1 (ko) 2008-02-22

Similar Documents

Publication Publication Date Title
PL357508A1 (pl) Sposób oczyszczania hCG oraz rekombinowana hCG oczyszczona tym sposobem
PL362891A1 (pl) Oczyszczony LH
IL98528A0 (en) Pharmaceutical compositions containing hybrid for killing bladder cancer cells
ZA932843B (en) A method of producing a factor VIII preparation
MXPA01010522A (es) Composiciones de gonadotropina altamente purificada y procedimiento para prepararlas.
ES2161790T3 (es) Procedimiento de separacion y de purificacion de proteinas dependientes de la vitamina k.
CA2213577A1 (en) A process for the preparation of factor ix from biological sources
CA2462232A1 (en) Method for reconstituting a recombinant protein to its biologically active form
KR950018050A (ko) 사람 글리센틴의 제조방법